Actively Recruiting
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
Led by Beijing GoBroad Hospital · Updated on 2025-06-03
8
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
Sponsors
B
Beijing GoBroad Hospital
Lead Sponsor
R
Ruijin Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Evaluate the Safety and Efficacy of JCXH-213 in Patients with Relapsed/Refractory B-cell non-Hodgkin Lymphoma
CONDITIONS
Official Title
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cytologically or histopathologically confirmed CD19-positive B-cell Hodgkin lymphoma based on WHO 2022 criteria, including diffuse large B-cell lymphoma, follicular lymphoma, histologically transformed lymphoma, primary mediastinal large B-cell lymphoma, or high-grade B-cell lymphoma
- ECOG performance status of 0 or 1
- Presence of measurable lesions meeting Lugano 2014 criteria: nodal lesions over 15 mm long axis or extra-nodal lesions over 10 mm long and short axes
You will not qualify if you...
- History of other malignant tumors within 5 years before screening, except adequately treated cervical carcinoma in situ, basal cell or squamous cell skin cancer, local radical prostatectomy, radical ductal carcinoma in situ, or radical thyroidectomy
- Active primary or secondary central nervous system involvement by B-cell non-Hodgkin lymphoma
- Life expectancy less than 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Lymphoma and Myeloma, Yuhengnan Road, Changping District, Beijing
Beijing, China
Actively Recruiting
Research Team
K
Kai Hu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here